Part II: The Preclinical Signal in Routine Abdominal CT: How Mayo's REDMOD and the Pre-Diagnostic Pancreas Force a Rethink of Cancer Screening Math, Workflow Economics, and the Multimodal Future of Risk Inference

Thoughts on Healthcare Markets & Technology Podcast

0:00

-9:50

Paid episode

The full episode is only available to paid subscribers of Thoughts on Healthcare Markets & Technology

Part II: The Preclinical Signal in Routine Abdominal CT: How Mayo's REDMOD and the Pre-Diagnostic Pancreas Force a Rethink of Cancer Screening Math, Workflow Economics, and the Multimodal Future of Risk Inference

Pancreatic cancer leaves detectable morphological signals in routine CT scans up to 18 months before diagnosis — and that changes the screening economics entirely.

May 04, 2026

∙ Paid

Quick Links: Knowledge Base, Podcast, and Social

Knowledge Base — search and filter every article and podcast episode by topic, section, and keyword: kb.onhealthcare.tech

Listen to the Podcast — every article is also available as an audio episode. Free subscribers get the public episodes; paid subscribers get the full archive including subscriber-only epi…

Continue reading this post for free, courtesy of Thoughts on Healthcare.

Or purchase a paid subscription.